157 related articles for article (PubMed ID: 25111531)
1. The sigma-1 receptor agonist 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) protects against newborn excitotoxic brain injury by stabilizing the mitochondrial membrane potential in vitro and inhibiting microglial activation in vivo.
Wegleiter K; Hermann M; Posod A; Wechselberger K; Stanika RI; Obermair GJ; Kiechl-Kohlendorfer U; Urbanek M; Griesmaier E
Exp Neurol; 2014 Nov; 261():501-9. PubMed ID: 25111531
[TBL] [Abstract][Full Text] [Related]
2. Targeting the sigma-1 receptor chaperone in the treatment of perinatal brain injury.
Hashimoto K
Exp Neurol; 2015 Mar; 265():118-21. PubMed ID: 25585013
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice.
Griesmaier E; Posod A; Gross M; Neubauer V; Wegleiter K; Hermann M; Urbanek M; Keller M; Kiechl-Kohlendorfer U
Exp Neurol; 2012 Oct; 237(2):388-95. PubMed ID: 22771763
[TBL] [Abstract][Full Text] [Related]
4. Sigma-1 receptor agonists provide neuroprotection against gp120 via a change in bcl-2 expression in mouse neuronal cultures.
Zhang Y; Shi Y; Qiao L; Sun Y; Ding W; Zhang H; Li N; Chen D
Brain Res; 2012 Jan; 1431():13-22. PubMed ID: 22133307
[TBL] [Abstract][Full Text] [Related]
5. Dextromethorphan is protective against sensitized N-methyl-D-aspartate receptor-mediated excitotoxic brain damage in the developing mouse brain.
Keller M; Griesmaier E; Auer M; Schlager G; Urbanek M; Simbruner G; Gressens P; Sárközy G
Eur J Neurosci; 2008 Feb; 27(4):874-83. PubMed ID: 18279363
[TBL] [Abstract][Full Text] [Related]
6. Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2.
Yang S; Bhardwaj A; Cheng J; Alkayed NJ; Hurn PD; Kirsch JR
Anesth Analg; 2007 May; 104(5):1179-84, tables of contents. PubMed ID: 17456670
[TBL] [Abstract][Full Text] [Related]
7. Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons.
Yang ZJ; Carter EL; Torbey MT; Martin LJ; Koehler RC
Exp Neurol; 2010 Jan; 221(1):166-74. PubMed ID: 19883643
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy.
Sokolowska P; Passemard S; Mok A; Schwendimann L; Gozes I; Gressens P
Neuroscience; 2011 Jan; 173():156-68. PubMed ID: 21073926
[TBL] [Abstract][Full Text] [Related]
9. Ontogenic study of the influence of tissue plasminogen activator (t-PA) in neonatal excitotoxic brain insult and the subsequent microglia/macrophage activation.
Hennebert O; Laudenbach V; Laquerriere A; Verney C; Carmeliet P; Marret S; Leroux P
Neuroscience; 2005; 130(3):697-712. PubMed ID: 15590153
[TBL] [Abstract][Full Text] [Related]
10. In vivo labeling of sigma receptors in mouse brain with [3H]4-phenyl-1-(4-phenylbutyl)piperidine.
Hashimoto K; Scheffel U; London ED
Synapse; 1995 May; 20(1):85-90. PubMed ID: 7624833
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production.
Goyagi T; Goto S; Bhardwaj A; Dawson VL; Hurn PD; Kirsch JR
Stroke; 2001 Jul; 32(7):1613-20. PubMed ID: 11441209
[TBL] [Abstract][Full Text] [Related]
12. Delayed application of the haematopoietic growth factors G-CSF/SCF and FL reduces neonatal excitotoxic brain injury.
Neubauer V; Wegleiter K; Posod A; Urbanek M; Wechselberger K; Kiechl-Kohlendorfer U; Keller M; Griesmaier E
Brain Res; 2016 Mar; 1634():94-103. PubMed ID: 26772988
[TBL] [Abstract][Full Text] [Related]
13. T3 replacement does not prevent excitotoxic cell death but reduces developmental neuronal apoptosis in newborn mice.
Sárközy G; Griesmaier E; He X; Kapelari K; Urbanek M; Simbruner G; Gressens P; Keller M
Eur J Paediatr Neurol; 2007 May; 11(3):129-35. PubMed ID: 17222575
[TBL] [Abstract][Full Text] [Related]
14. The σ 1 receptor agonist 4-PPBP elicits ERK1/2 phosphorylation in primary neurons: a possible mechanism of neuroprotective action.
Tan F; Guio-Aguilar PL; Downes C; Zhang M; O'Donovan L; Callaway JK; Crack PJ
Neuropharmacology; 2010 Nov; 59(6):416-24. PubMed ID: 20538010
[TBL] [Abstract][Full Text] [Related]
15. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in cats.
Takahashi H; Kirsch JR; Hashimoto K; London ED; Koehler RC; Traystman RJ
Stroke; 1995 Sep; 26(9):1676-82. PubMed ID: 7544928
[TBL] [Abstract][Full Text] [Related]
16. Systemic application of granulocyte-colony stimulating factor and stem cell factor exacerbates excitotoxic brain injury in newborn mice.
Keller M; Simbruner G; Górna A; Urbanek M; Tinhofer I; Griesmaier E; Sarkozy G; Schwendimann L; Gressens P
Pediatr Res; 2006 Apr; 59(4 Pt 1):549-53. PubMed ID: 16549527
[TBL] [Abstract][Full Text] [Related]
17. Potent sigma 1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats.
Goyagi T; Bhardwaj A; Koehler RC; Traystman RJ; Hurn PD; Kirsch JR
Anesth Analg; 2003 Feb; 96(2):532-8, table of contents. PubMed ID: 12538208
[TBL] [Abstract][Full Text] [Related]
18. Cyclic adenosine monophosphate response element-binding protein phosphorylation and neuroprotection by 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP).
Yang S; Alkayed NJ; Hurn PD; Kirsch JR
Anesth Analg; 2009 Mar; 108(3):964-70. PubMed ID: 19224810
[TBL] [Abstract][Full Text] [Related]
19. The common antitussive agent dextromethorphan protects against hyperoxia-induced cell death in established in vivo and in vitro models of neonatal brain injury.
Posod A; Pinzer K; Urbanek M; Wegleiter K; Keller M; Kiechl-Kohlendorfer U; Griesmaier E
Neuroscience; 2014 Aug; 274():260-72. PubMed ID: 24912029
[TBL] [Abstract][Full Text] [Related]
20. sigma-1 receptors protect RGC-5 cells from apoptosis by regulating intracellular calcium, Bax levels, and caspase-3 activation.
Tchedre KT; Yorio T
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2577-88. PubMed ID: 18296662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
